Correction: Moeker, N.; et al. Antibody Selection for Cancer Target Validation of FSH-Receptor in Immunohistochemical Settings. Antibodies 2017, 6, 15

Abstract

The authors wish to make the following correction to the Conflict of Interests section in their published paper [1]:"Christian Kunz and Solveig Peters are employees and Nina Möker and Robert Rauchenberger are former employees of MorphoSys AG, which owns the Ylanthia antibodies described in the publication."The manuscript will be updated and the original will remain online on the article webpage.